News & Updates

Show Multimedia Only
High acute-to-chronic glycaemic ratio tied to worse prognosis in T2D patients with COVID-19

High acute-to-chronic glycaemic ratio tied to worse prognosis in T2D patients with COVID-19

23 Nov 2021

Type 2 diabetes (T2D) patients with COVID-19 who have elevated acute-to-chronic (A/C) glycaemic ratio are at increased risk of adverse outcomes, including in-hospital mortality, intensive care unit (ICU) admission, and mechanical ventilation, a study has found.

23 Nov 2021
Liraglutide cuts renal triglyceride content in diabetics Liraglutide cuts renal triglyceride content in diabetics

Liraglutide cuts renal triglyceride content in diabetics

22 Nov 2021

In type 2 diabetes mellitus patients, glycaemic control through liraglutide reduces renal triglyceride content, a recent study has found.

22 Nov 2021
Amphilimus-eluting stents: As good as zotarolimus-eluting stents in patients with diabetes?

Amphilimus-eluting stents: As good as zotarolimus-eluting stents in patients with diabetes?

22 Nov 2021 byRoshini Claire Anthony

The use of amphilimus-eluting stents (AES) in patients with diabetes mellitus undergoing percutaneous revascularization was less likely to result in target lesion or target vessel failure compared with zotarolimus-eluting stents (ZES) at 1 year, according to findings of the SUGAR trial presented at TCT 2021.

22 Nov 2021